Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex (Q34558599)

3 August 2017

title

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex (English)

1 reference

3 August 2017

0 references

0 references

1 reference

1 reference

3

K J Weinhold

1 reference

3 August 2017

R Yarchoan

1

1 reference

3 August 2017

R W Klecker

2

1 reference

3 August 2017

P D Markham

4

1 reference

3 August 2017

H K Lyerly

5

1 reference

3 August 2017

D T Durack

6

1 reference

3 August 2017

E Gelmann

7

1 reference

3 August 2017

S N Lehrman

8

1 reference

3 August 2017

R M Blum

9

1 reference

3 August 2017

D W Barry

10

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 March 1986

1 reference

3 August 2017

1 reference

3 August 2017

volume

1

1 reference

3 August 2017

issue

8481

1 reference

3 August 2017

page(s)

575-580

1 reference

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2992808-4

7 January 2021

Synthesis and biological activity of several amino analogues of thymidine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2992808-4

7 January 2021

Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in hum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2992808-4

7 January 2021

Quantification of tiazofurin in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2992808-4

7 January 2021

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2992808-4

7 January 2021

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2992808-4

7 January 2021

HTLV-III infection in brains of children and adults with AIDS encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2992808-4

7 January 2021

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2992808-4

7 January 2021

Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2992808-4

7 January 2021

Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2992808-4

7 January 2021

Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2992808-4

7 January 2021

Adaptation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2992808-4

7 January 2021

10.1016/S0140-6736(86)92808-4

Identifiers

DOI

1 reference

3 August 2017

1 reference